ILIAS Biologics’ exosomes for sepsis; plus regulating cocaine seeking and a new COVID-19 target

BioCentury’s roundup of preclinical news

Relieving sepsis-related organ damage
An ILIAS Biologics Inc. and Korea Advanced Institute of Science and Technology team described in Science Advances a sepsis treatment comprising exosomes loaded with a “super repressor”

Read the full 302 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE